Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3781 AL 3795

The blood brain barrier in Alzheimer's disease

Chakraborty A, de Wit NM, van der Flier WM, de Vries HE.

Vascul Pharmacol. 2017 Feb;89:12-18. doi: 10.1016/j.vph.2016.11.008. Epub 2016 Nov 25.

Sleep disturbance: an emerging opportunity for Alzheimer's disease prevention?

Spira AP, Gottesman RF.

Int Psychogeriatr. 2017 Apr;29(4):529-531. doi: 10.1017/S1041610216002131. Epub 2016 Dec 12.

Editorial (Thematic Issue: Endocrine Disorders and Cognitive Function in the Elderly)

Pasqualetti G, Calsolaro V, Monzani F.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):2-3. doi: 10.2174/187221481001161005181628.

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

Wallin A, Nordlund A, Jonsson M, Lind K, Edman Å, Göthlin M, Stålhammar J, Eckerström M, Kern S, Börjesson-Hanson A, Carlsson M, Olsson E, Zetterberg H, Blennow K, Svensson J, Öhrfelt A, Bjerke M, Rolstad S, Eckerström C.

J Cereb Blood Flow Metab. 2016 Jan;36(1):114-31. doi: 10.1038/jcbfm.2015.147.

Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

Wallin A, Nordlund A, Jonsson M, Blennow K, Zetterberg H, Öhrfelt A, Stålhammar J, Eckerström M, Carlsson M, Olsson E, Göthlin M, Svensson J, Rolstad S, Eckerström C, Bjerke M.

J Cereb Blood Flow Metab. 2016 Jan;36(1):95-113. doi: 10.1038/jcbfm.2015.148.

Blood-based biomarkers of Alzheimer's disease: diagnostic algorithms and new technologies

Carmona P, Molina M, Toledano A.

Curr Alzheimer Res. 2016;13(4):450-64. doi: 10.2174/1567205013666151116130301.

Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis

Xu J, Xia LL, Song N, Chen SD, Wang G.

Curr Alzheimer Res. 2016;13(3):215-22. doi: 10.2174/1567205013666151218145752.

Alzheimer's disease: the amyloid hypothesis on trial

Harrison JR, Owen MJ.

Br J Psychiatry. 2016 Jan;208(1):1-3. doi: 10.1192/bjp.bp.115.167569.

Oxidative challenge in Alzheimer's disease: state of knowledge and future needs

Cervellati C, Wood PL, Romani A, Valacchi G, Squerzanti M, Sanz JM, Ortolani B, Zuliani G.

J Investig Med. 2016 Jan;64(1):21-32. doi: 10.1136/jim-2015-000017.

Biochemical and Radiological Markers of Alzheimer's Disease Progression

Dziedzic T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, Slowik A.

J Alzheimers Dis. 2016;50(3):623-44. doi: 10.3233/IFS-150578.

Suspected non-Alzheimer disease pathophysiology--concept and controversy

Jack CR Jr, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ.

Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18.

Rethinking on the concept of biomarkers in preclinical Alzheimer's disease

Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A.

Neurol Sci. 2016 May;37(5):663-72. doi: 10.1007/s10072-016-2477-1. Epub 2016 Jan 20.

Amyloid imaging: Past, present and future perspectives

Villemagne VL.

Ageing Res Rev. 2016 Sep;30:95-106. doi: 10.1016/j.arr.2016.01.005. Epub 2016 Jan 28.

Neuroimaging biomarkers in Alzheimer's disease and other dementias

Villemagne VL, Chételat G.

Ageing Res Rev. 2016 Sep;30:4-16. doi: 10.1016/j.arr.2016.01.004. Epub 2016 Jan 28.

Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives

Wang J, Tan L, Yu JT.

J Alzheimers Dis. 2016;50(4):927-45. doi: 10.3233/JAD-150826.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias